Venture Capital Investors

Beyond Celiac Investments

Beyond Celiac Investments is a VC investing group that helps tech companies with financing and expertise.

Venture Investor Overview

Contact Information

Background Information

Overview

Beyond Celiac Investments (BCI) accelerates the development of treatments toward a cure for celiac disease by leveraging the speed and scale of venture capital and capital markets. BCI launched in February of 2024 with an initial funding of $2 million. Beyond Celiac developed BCI to accelerate drug development using the proven venture philanthropy model. Before the launch of BCI, no celiac or autoimmune-focused venture funds existed.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

12/22/2025

Transaction History

Our records indicate that Beyond Celiac Investments invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Chief Executive Officer

Alice Bast

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Beyond Celiac Investments has invested in only one tech company, according to our database records. If we are missing a portfolio company, please let us know.

Browse more venture capital investors:

Beyond Capital Ventures | Beyond Impact

Share this article

About Our VC Investors Database

This VC firm profile is powered by VentureDeal.com, a market leader in private equity transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary